Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis.
Tappenden P, Saccardi R, Confavreux C, Sharrack B, Muraro PA, Mancardi GL, Kozak T, Farge-Bancel D, Madan J, Rafia R, Akehurst R, Snowden J. Tappenden P, et al. Among authors: sharrack b. Bone Marrow Transplant. 2010 Jun;45(6):1014-21. doi: 10.1038/bmt.2009.305. Epub 2009 Oct 26. Bone Marrow Transplant. 2010. PMID: 19855441
Autologous hematopoietic cell transplantation in multiple sclerosis.
Bell SM, Sharrack B, Snowden JA. Bell SM, et al. Among authors: sharrack b. Expert Opin Biol Ther. 2017 Jan;17(1):77-86. doi: 10.1080/14712598.2017.1239706. Epub 2016 Oct 14. Expert Opin Biol Ther. 2017. PMID: 27657737 Free article. Review.
Blogs cannot separate wheat from chaff.
Burt RK, Snowden JA, Burman J, Oliveira MC, Sharrack B. Burt RK, et al. Among authors: sharrack b. Science. 2017 Nov 3;358(6363):602. doi: 10.1126/science.aar2575. Science. 2017. PMID: 29097540 No abstract available.
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA, Carlson K, Han X, Moraes D, Morgan A, Quigley K, Yaung K, Buckley R, Alldredge C, Clendenan A, Calvario MA, Henry J, Jovanovic B, Helenowski IB. Burt RK, et al. Among authors: sharrack b. JAMA. 2019 Jan 15;321(2):165-174. doi: 10.1001/jama.2018.18743. JAMA. 2019. PMID: 30644983 Free PMC article. Clinical Trial.
General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
Jessop H, Farge D, Saccardi R, Alexander T, Rovira M, Sharrack B, Greco R, Wulffraat N, Moore J, Kazmi M, Badoglio M, Adams G, Verhoeven B, Murray J, Snowden JA. Jessop H, et al. Among authors: sharrack b. Bone Marrow Transplant. 2019 Jul;54(7):933-942. doi: 10.1038/s41409-019-0430-7. Epub 2019 Jan 31. Bone Marrow Transplant. 2019. PMID: 30705338 Free PMC article. Review.
216 results